Comparative 2-year drug survival of bimekizumab and brodalumab in second-line treatment of psoriasis.

Saved in:
Bibliographic Details
Title: Comparative 2-year drug survival of bimekizumab and brodalumab in second-line treatment of psoriasis.
Authors: Schwarz CW; Department of Dermatology and Allergy, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark. Electronic address: christopher.willy.schwarz.01@regionh.dk., Loft N; Department of Dermatology and Allergy, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark., Bryld LE; Department of Dermatology, Zealand University Hospital, Roskilde, Denmark., Nissen CV; Department of Dermatology, Copenhagen University Hospital - Bispebjerg, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Svendsen MT; Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Bertelsen T; Hudlaegecenter Nord, Aalborg, Denmark., Hjuler KF; Department of Dermatology, Aalborg University Hospital, Aalborg, Denmark., Dam TN; Dermatology Clinic, Nykoebing Falster, Denmark., Rasmussen MK; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark., Skov L; Department of Dermatology and Allergy, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2026 Apr 24. Date of Electronic Publication: 2026 Apr 24.
Publication Type: Journal Article
Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-6787
DOI:10.1016/j.jaad.2026.04.1925